What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Inside Trump’s Twitter Clone
Can A.I. Know What You're Feeling?
Is Free Speech Online Just a Myth?
Can the Internet Rescue Abortion Access?
The Fantasy of Internet for All
What Elon Wants With Twitter
A New High-Tech Weapon in Ukraine
The COVID Data Disaster
How TurboTax Tricks Taxpayers
Elonnnnnnnnnnnnn!
Uber Makes Nice With Cabs
Elon Trolls the SEC
A Conversation With Europe's Top Tech Cop
The White House's Favorite Tech Billionaire
The Cost of Going Off-Grid
Why the Zelensky Deepfake Failed
The Startup Delivering Adderall
Hong Kong’s Covid Crisis
How Minnesota Spied On Protesters
Putin's Internet Crackdown
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts